WebThe latest 13F hedge fund activity and institutional ownership for AYTU, showing biggest buyers/sellers of Aytu Biopharma Inc. Web81 rows · Aytu BioScience, Inc. (US:AYTU) has 50 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). … Aytu BioPharma, Inc.: Aytu BioPharma to Report Second Quarter Fiscal 2024 … AYTU / Aytu BioScience, Inc. off-exchange short sale volume is shown in the … Aytu BioScience, Inc. Warrant (US:AYTUZ) has 0 institutional owners and …
Aytu BioScience Inc. (AYTU): Wow - NICE!>> 2024-05-15 …
WebSee photos and price history of this 3 bed, 1 bath, 1,195 Sq. Ft. recently sold home located at 3213 N Tindle Blvd, Flagstaff, AZ 86004 that was sold on 09/20/2024 for $415000. WebView 13F filing holders of AYTU BIOSCIENCE INC INV WT EXP. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. ... Aytu … cordless reciprocating saw long stroke
AYTU Holdings Changes
WebNov 26, 2024 · In terms of the portfolio weights assigned to each position Beech Hill Partners allocated the biggest weight to Aytu BioScience, Inc. (NASDAQ:AYTU), around 0.02% of its 13F portfolio. WebProfile. Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline ... WebApr 11, 2024 · Their AYTU share price forecasts range from $5.00 to $6.00. On average, they anticipate the company's share price to reach $5.50 in the next twelve months. This suggests a possible upside of 134.0% from the stock's current price. View analysts price targets for AYTU or view top-rated stocks among Wall Street analysts. cordless ring doorbell